Innovus Pharmaceuticals Inc. (fka INNV)

[Drugdoctor]

$AKRX-got-the-ANDA-for-$INNV's-product, and-this-is-their-situation...

I don't think this is the past, bro! But these two companies deserve each other, that's for sure, based on their charts, lol

Wonder who else they will let market their fluticasone spray??

Douglas Boothe, Akorn’s President and Chief Executive Officer, stated, “We are excited to add to our Fluticasone franchise and look forward to expanding into the over-the-counter (OTC) market. Among other private label possibilities, we have a supply agreement in place for Fluticare® through Innovus Pharmaceuticals, Inc. (OTCQB Venture Market: INNV).”

Fluticasone propionate nasal spray USP, 50 mcg per spray is indicated for the temporary relief of hay fever and other upper respiratory allergies in adult and pediatric patients 4 years of age and older.

Fluticare® is a registered trademark of Innovus Pharmaceuticals, Inc.

Both company charts are a disaster...